NanoEcho AB (publ) (NANECH.ST)
Stockholm · SEK · Healthcare · Biotechnology
SEK 0.013 (+0.00%) as of
Key statistics
- Market cap
- 6.11M
- EPS (TTM)
- -0.0400
- Dividend yield
- 0.00%
- 52-week range
- 0.0128 – 0.1050
- Beta
- 0.88
- Revenue (TTM)
- 974k
- Profit margin
- 0.00%
- Volume
- 5.91M
About NanoEcho AB (publ)
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Lund, Sweden
- Employees
- 5
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.